|
⚲
|
| Keyboard |
| Darren Kearns | |
|---|---|
| Firm | |
| Address | 40 S Main Street Suite 1900 Memphis, TN 38103 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| GT Private Equity XII LP | 021-575264 | Executive Officer | 8.7 M of 250.0 M |
||
| GT Co-Invest II LP | 021-545643 | Executive Officer | 36.2 M of 75.0 M |
||
| GT Insurance II LP | 021-288310 | Executive Officer | 21.3 M | ||
| GT Asset Allocation Fund LP | 021-93244-6A | Executive Officer | 396.1 M | ||
| GT Global Hedge LP | 021-93256-4A | Executive Officer | 3,099.8 M | ||
| GT International Equity Fund LP | 021-96038 | Executive Officer | 143.3 M | ||
| GT International Equity QP Fund LP | 021-96057 | Executive Officer | 777.6 M | ||
| GT Partners LP | 021-87151-8A | Executive Officer | 4,229.7 M | ||
| GT US Fund LP | 021-96036 | Executive Officer | 133.5 M | ||
| GT US QP Fund LP | 021-96058 | Executive Officer | 467.5 M | ||
| Gerber/Taylor Management LLC | |||||
| GT Private Equity Xi LP | 021-480617 | Executive Officer | 179.8 M of 250.0 M |
228.1 M | |
| GT Real Assets IV LP | 021-461601 | Executive Officer | 45.9 M of 75.0 M |
53.0 M | |
| GT Windward I LP | 021-472514 | Executive Officer | 53.0 M | 64.3 M | |
| GT Biotech Fund LP | 021-362969 | Executive Officer | 229.3 M | 358.3 M | |
| GT Special Opportunities III-A LP | 021-330636 | Executive Officer | 63.1 M | 41.4 M | |
| GT Insurance LP | 021-150147 | Executive Officer | 37.9 M | 55.2 M | |
| GT Emerging Markets QP LP | 021-129801 | Executive Officer | 489.3 M | 114.3 M | |
| GT Special Opportunities III LP | 021-163420 | Executive Officer | 156.5 M | 150.3 M | |